Athenex, Inc.
News
Behind the deal: What Pine Pharmaceuticals got from Athenex
BizJournals.com - Nat'l Business News Over the last several months, Pine Pharmaceuticals in Tonawanda has worked to onboard several new products, processes and 50 former Athenex employees. "It was a very big lift," said Alfonse J. Muto Jr., who owns Pine with his father, Alfonse Muto Sr. Athenex Inc.\n more…
Athenex to lay off 123 WNY employees, close both Buffalo-area plants by mid-August
Bizjournals.com: Manufacturing Just days after filing for bankruptcy, Athenex Inc. has filed a WARN notice with the state Department of Labor for its 123 Western New York employees. Athenex (Nasdaq: ATNX) will close both its locations - in the Conventus Building on Main Street in Buffalo and at 11342 Main St.\n more…
Athenex, Inc. (NASDAQ:ATNX) Short Interest Down 9.9% in April
Zolmax Athenex, Inc. (NASDAQ:ATNX Get Rating) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 356,300 shares, a decline of 9.9% from the April 15th total of 395,500 shares. Based on an average daily trading...\n more…
Athenex files for bankruptcy, announces plans to sell assets
Bizjournals.com: Manufacturing Athenex Inc. has filed for bankruptcy and will attempt to sell its assets by July 1. The troubled biopharmaceutical company (Nasdaq: ATNX) - along with its subsidiaries, Athenex Pharmaceutical Division, Orascovery and Cell Therapy - filed the Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of Texas, according to a news release.\n more…
Athenex Voluntarily Filed For Chapter 11 Proceedings, Shares Plunge
Benzinga On Sunday, Athenex Inc ATNX and certain of its subsidiaries voluntarily filed for Chapter 11 proceedings. Athenex agreed with its lenders to move forward with an expedited sale process of its assets, the company said in a statement. The company has listed estimated assets and liabilities of around $100 million-$500 million, Reuters reported citing a filing with the U.S.\n more…
